NIH funded biotech startup website design

This, from a month ago, for a biotech startup with recent NIH funding and the support of the University of Pennsylvania.

Their technology allows medical facilities to test blood clot formation in-vivo, giving doctors real-time evaluation of blood clot physiology and clotting abnormalities; preventing blood clots and preventing uncontrolled bleeding deaths.

I really enjoyed helping this group express their very complicated new technology to investors. They've seen solid traction from the rebrand and website; the group has already received additional investment interest.

More about the client's product:

FloBio is developing a point-of care IVD product that includes a table top analyzer, disposable cartridge and proprietary software. The device combines hemodynamic flow and discrete lot activation to facilitate real-time evaluation of blood clot physiology and clotting abnormalities. FloBio's diagnostic platform is being designed to identify the actual hemostasis abnormality which could help clinicians optimize clinical decision making, while positively impacting hospitals’ blood product stewardship and DOAC/blood thinner safe use goals. The technology also has potential applications in emergency trauma care where surgical/procedural and treatment decisions can be made more quickly in order to avoid severe bleeding complications.